Bright Peak are developing a portfolio of first-in-class and best-in-class cytokines with optimized biological properties for the treatment of cancer and autoimmune diseases. Through a variety of proprietary technology platforms, Bright Peak is uniquely abled to conjugate its cytokines as payloads to antibodies, creating bespoke, novel and proprietary “Bright Peak Immunocytokines”, and to other cytokines as “duokines”.
The Bright Peak Immunocytokines allow tissue- and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy. One of the many advantages of our approach is its "off-the-shelf" feature. Using a pioneering site-specific ADC-like chemical conjugation technology, any therapeutic antibody at any stage of development can be conjugated with Bright Peak’s cytokine payloads of choice, eliminating the current complexities of antibody engineering and cell line development.
Bright Peak’s team works with a passion for innovation and bold science. We are an international research-driven organization dedicated to discovering and developing cutting edge therapies that will make a difference in the lives of patients. We aim to create a vibrant and international corporate culture and are currently hiring in our Basel, Switzerland and Southern California locations.
Company Details
- Employees
- 51
- Founded
- -
- Address
- Klybeckstrasse 191,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.brightpeaktx.com/
- Keywords
- SkyCell AG.
- HQ
- Basel
Bright Peak Therapeutics Questions
Bright Peak Therapeutics's website is https://www.brightpeaktx.com/
Bright Peak Therapeutics's LinkedIn profile is https://www.linkedin.com/company/bright-peak-therapeutics
Bright Peak Therapeutics has
51 employees.
View email and phone details for 51
employees at Bright Peak Therapeutics.
Bright Peak Therapeutics's industry is
Biotechnology Research
Bright Peak Therapeutics's top competitors are
Monte Rosa Therapeutics,
Skycell Ag,
Noema Pharma,
Ridgeline Discovery,
Alentis Therapeutics,
Atlas Agro,
Immunos Therapeutics Ag,
Asceneuron Sa,
Ionctura,
Neustark.
Bright Peak Therapeutics's categories are Biotechnology Research
Bright Peak Therapeutics's founding year is 2017
